Search research articles
Contact Us
Filters
Showing results (81-90 of 104) with videos related to
Page
of 11
Sort By:
Journal of Immunological Methods
|
June 1, 2024
Establishment of human post-vaccination SARS-CoV-2 standard reference sera
Jinhua Xiang, Louis Katz, Patricia L Winokur, et al.
Nature Communications
|
August 10, 2017
A Plasmodium yoelii HECT-like E3 ubiquitin ligase regulates parasite growth and virulence
Sethu C Nair, Ruixue Xu, Sittiporn Pattaradilokrat, et al.
Genome Biology
|
February 17, 2009
Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum
Neekesh V Dharia, Amar Bir Singh Sidhu, María Belén Cassera, et al.
ACS Pharmacology & Translational Science
|
December 21, 2020
Modulation of Triple Artemisinin-Based Combination Therapy Pharmacodynamics by <i>Plasmodium falciparum</i> Genotype
Megan R Ansbro, Zina Itkin, Lu Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 24, 2020
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors
Rachel P M Abrams, Adam Yasgar, Tadahisa Teramoto, et al.
Journal of Natural Products
|
October 15, 2015
Actinoramide A Identified as a Potent Antimalarial from Titration-Based Screening of Marine Natural Product Extracts
Ken Chih-Chien Cheng, Shugeng Cao, Avi Raveh, et al.
Antimicrobial Agents and Chemotherapy
|
November 7, 2012
A class of tricyclic compounds blocking malaria parasite oocyst development and transmission
Richard T Eastman, Sittiporn Pattaradilokrat, Dipak K Raj, et al.
Biorxiv : the Preprint Server for Biology
|
August 26, 2020
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Catherine Z Chen, Paul Shinn, Zina Itkin, et al.
Frontiers in Pharmacology
|
March 12, 2021
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Catherine Z Chen, Paul Shinn, Zina Itkin, et al.
Antimicrobial Agents and Chemotherapy
|
August 14, 2013
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers
Pharath Lim, Dalin Dek, Vorleak Try, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 104) with videos related to
Sort By:
Page
of 11
Journal of Immunological Methods
|
June 1, 2024
Establishment of human post-vaccination SARS-CoV-2 standard reference sera
Jinhua Xiang, Louis Katz, Patricia L Winokur, et al.
Nature Communications
|
August 10, 2017
A Plasmodium yoelii HECT-like E3 ubiquitin ligase regulates parasite growth and virulence
Sethu C Nair, Ruixue Xu, Sittiporn Pattaradilokrat, et al.
Genome Biology
|
February 17, 2009
Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum
Neekesh V Dharia, Amar Bir Singh Sidhu, María Belén Cassera, et al.
ACS Pharmacology & Translational Science
|
December 21, 2020
Modulation of Triple Artemisinin-Based Combination Therapy Pharmacodynamics by <i>Plasmodium falciparum</i> Genotype
Megan R Ansbro, Zina Itkin, Lu Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 24, 2020
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors
Rachel P M Abrams, Adam Yasgar, Tadahisa Teramoto, et al.
Journal of Natural Products
|
October 15, 2015
Actinoramide A Identified as a Potent Antimalarial from Titration-Based Screening of Marine Natural Product Extracts
Ken Chih-Chien Cheng, Shugeng Cao, Avi Raveh, et al.
Antimicrobial Agents and Chemotherapy
|
November 7, 2012
A class of tricyclic compounds blocking malaria parasite oocyst development and transmission
Richard T Eastman, Sittiporn Pattaradilokrat, Dipak K Raj, et al.
Biorxiv : the Preprint Server for Biology
|
August 26, 2020
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Catherine Z Chen, Paul Shinn, Zina Itkin, et al.
Frontiers in Pharmacology
|
March 12, 2021
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Catherine Z Chen, Paul Shinn, Zina Itkin, et al.
Antimicrobial Agents and Chemotherapy
|
August 14, 2013
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers
Pharath Lim, Dalin Dek, Vorleak Try, et al.
Page
of 11